Why Is Life Science Focused Bruker Stock Trading Higher On Friday?
1. BRKR's Q1 revenue estimated at $795M-$800M, exceeding consensus of $758.85M. 2. 10-11% year-over-year increase reflects strong performance in scientific instruments. 3. Collaboration with Ridom GmbH for NGS bioinformatics enhances BRKR's microbiology solutions. 4. High-teens percentage decline in BEST segment could impact overall growth. 5. BRKR stock rose 2.47% to $39.01 premarket following revenue announcement.